Bibliographic Info
Recommendation
Recommended in favor
Strong
Certainty of evidence
High
Artemisinin-based combination therapies (ACTs) should include at least 3 days of treatment with an artemisinin derivative.
Notes and Remarks
Addition of a single dose primaquine (0.75 mg/kg) to ACT treatment for uncomplicated falciparum malaria as an antigametocyte medicine, particularly as a component of pre-elimination or an elimination programme.
Also Featured In
This recommendation also appears in the following guidelines:
Guidelines for the treatment of malaria
WHO guidelines for malaria, 16 February 2021.
WHO guidelines for malaria, 13 July 2021.
WHO guidelines for malaria, 18 February 2022.
WHO guidelines for malaria, 31 March 2022.
WHO guidelines for malaria, 3 June 2022.
WHO guidelines for malaria, 25 November 2022.
WHO guidelines for malaria, 16 October 2023.
WHO Guidelines for malaria, 14 March 2023
WHO guidelines for malaria, 30 November 2024.